Correction to: BCL2L2 loss renders ‐14q renal cancer dependent on BCL2L1 that mediates resistance to tyrosine kinase inhibitors

Detalles Bibliográficos
Autores principales: Lyu, Yinfeng, Li, Kunping, Li, Yuqing, Wen, Hui, Feng, Chenchen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Erratum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10199167/
https://www.ncbi.nlm.nih.gov/pubmed/37208846
http://dx.doi.org/10.1002/ctm2.1268

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10199167/
https://www.ncbi.nlm.nih.gov/pubmed/37208846
http://dx.doi.org/10.1002/ctm2.1268

Ejemplares similares